Loading…
avatar for Phil Ball

Phil Ball

Independent Consultant
Health Policy, Biopharmaceutical Development Strategy
Phil Ball has over twenty years of international experience spanning from pharmaceutical product development to health policy. Most recently he was Executive Director, U.S. Value Policy and Strategy, at Allergan. In this role he led U.S. HEOR- and value-related policy and legislative initiatives, catalyzing these activities across the organization and with external stakeholders. Previously, he was responsible for Biologics Policy and Strategy, leading global biosimilars policy development and acting as a principal alliance manager for multi-product collaborations. Phil holds a BSc in biochemistry from the University of Manchester and a PhD in biochemistry from the University of Liverpool.